TIANSHAN BIO(SZ:300313)2025-01-24 08:45Financial Performance Expectations - The company expects a net loss of between 63 million and 75 million yuan for the fiscal year 2024, compared to a net loss of 22.0016 million yuan in the same period last year [2]. - The projected operating revenue for 2024 is between 120 million and 150 million yuan, a decrease from 137.4999 million yuan in the previous year [2]. - The company's net assets are expected to be between -12 million and -1 million yuan at the end of 2024, down from 62.1686 million yuan at the end of the previous year [2]. Market Conditions and Challenges - The decline in revenue is attributed to a downturn in the domestic beef cattle market, leading to reduced income from live livestock operations [5]. - The company has seen a decrease in sales of frozen semen due to lower demand from cattle breeding enterprises amid the market downturn [5]. - New meat processing and sales operations in Guangdong are still in the early stages and have not yet stabilized, leading to cautious revenue recognition [5]. - The company has recognized impairment provisions for biological assets and inventory due to declining market prices [5]. Risk Factors - There is a risk of delisting if the audited net profit is negative and operating revenue falls below 100 million yuan [6]. Financial Reporting - The financial data presented is preliminary and has not been audited by an external accounting firm [3]. - The company will provide detailed financial data in the 2024 annual report [8].